SEC Form 4
Bristol-Myers Squibb Co. (BMY) insider trading
In the 12 months to Oct 23, 2026, 3 BMY insiders reported open-market sales of $2.3M across 3 filings; no open-market purchases were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $2.3M
- 3 filings · 3 insiders
- Open-market purchases
- $0
- 0 filings
Who traded BMY, and when
- Sale
BMY daily close from Oct 23, 2025 to Oct 23, 2026, between $42.60 and $68.09, last $61.48. 3 sale and 0 purchase filings by 3 insiders, marked at their filing dates. David V. Elkins, EVP, Chief Financial Officer: sold $1.9M across 1 filing, first filed Apr 2, 2026, last Apr 2, 2026. Cristian Massacesi, EVP,Chief Med Offr,Head of Dev: sold $403.5K across 1 filing, first filed Sep 10, 2026, last Sep 10, 2026. Phil M. Holzer, SVP and Controller: sold $33.8K across 1 filing, first filed Aug 26, 2026, last Aug 26, 2026.
Largest mark · tap a row for others
David V. Elkins · EVP, Chief Financial Officer
Sale $1,850,016
30,000 shares at $61.67 avg
Filed Apr 2, 2026 · traded Apr 1
Close on filing date $59.60
David V. Elkins · EVP, Chief Financial Officer
EVP, Chief Financial Officer
$1.9M soldCristian Massacesi · EVP,Chief Med Offr,Head of Dev
EVP,Chief Med Offr,Head of Dev
$403.5K soldPhil M. Holzer · SVP and Controller
SVP and Controller
$33.8K soldHas Bristol-Myers Squibb Co.'s CEO sold stock?
No. Christopher S. Boerner (CEO) made no open-market sales filed as CEO in the last 12 months.
Open-market trades
3 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| David V. Elkins | EVP, Chief Financial Officer | $1.9M | — | 1 | — | |
| Cristian Massacesi | EVP,Chief Med Offr,Head of Dev | $403.5K | — | 1 | — | |
| Phil M. Holzer | SVP and Controller | $33.8K | — | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Cristian Massacesi EVP,Chief Med Offr,Head of Dev | Sale | 6,249 | $64.57 | $403.5K | 18,748 | |
traded | Phil M. Holzer SVP and Controller | Sale | 500 | $67.50 | $33.8K | 16,862 | |
traded | David V. Elkins EVP, Chief Financial Officer | Sale | 30,000 | $61.67 | $1.9M | 159,248 |
GET /stocks/filings/vX/form-4?tickers=BMY&filing_date.gte=2025-10-23&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"BMY",
"CELGr"
],
"issuer_cik": "0000014272",
"owner_cik": "0002080176",
"accession_number": "0002080176-26-000006",
"form_type": "4",
"filing_date": "2026-09-10",
"period_of_report": "2026-09-09",
"issuer_name": "BRISTOL MYERS SQUIBB CO",
"issuer_trading_symbol": "BMY",
"owner_name": "Massacesi Cristian",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "EVP,Chief Med Offr,Head of Dev",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock, $0.10 par value",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-09-09",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 6249,
"transaction_price_per_share": 64.57,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 18748,
"transaction_value": 403497.92999999993,
"not_subject_to_section_16": false,
"direct_or_indirect": "D"
},
{
"tickers": [
"BMY",
"CELGr"
],
"issuer_cik": "0000014272",
"owner_cik": "0002012588",
"accession_number": "0002012588-26-000004",
"form_type": "4",
"filing_date": "2026-08-26",
"period_of_report": "2026-08-25",
"issuer_name": "BRISTOL MYERS SQUIBB CO",
"issuer_trading_symbol": "BMY",
"owner_name": "Holzer Phil M",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "SVP and Controller",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock, $0.10 par value",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-08-25",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 500,
"transaction_price_per_share": 67.5,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 16862,
"transaction_value": 33750,
"not_subject_to_section_16": false,
"direct_or_indirect": "D"
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 134 records
- Option exercises49 records
- Tax withholding48 records
- Other37 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
Build this yourself
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for BMY every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.